The primary objective of the Genomics, Proteomics and Drug Discovery program is to train individuals with expertise to pursue an independent research career in the post-genomic era by adopting a multidisciplinary approach that integrate in theory and practice the principles of molecular biology, genetics, structural biology, chemistry and computation. Students seek to understand the function of genes and proteins and use this knowledge for the discovery of novel chemical entities to modify a disease process by applying the latest technology in genomic, proteomic and chemical sciences, including genotyping, microarray, structural, synthetic, computational and combinatorial chemistry. Students use computational, biochemical and cell-based screening technologies to identify natural and synthetic compounds with pharmacological activity. Students also study structure-activity relationships to understand the mechanisms of drug action.
Primary Contact:
Song Li, MD, PhD
Assistant Professor
639 Salk Hall
Pittsburgh, PA 15213
Phone: (412)-383-7976
Email: sol4@pitt.edu